HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary neuroendocrine carcinoma of the appendix: a case report and review of the literature.

AbstractAIM:
We report on a rare case of appendiceal primary neuroendocrine carcinoma (NEC) and discuss three cases previously described.
CASE REPORT:
A 58-year-old woman presented with acute abdominal pain and a low-grade fever. She was diagnosed with acute appendicitis and underwent laparoscopic appendectomy. Pathological examination of the resected specimen revealed NEC. Immunohistochemical analyses were positive for synaptophysin, chromogranin, and CD-56. The tumour was high grade and the Ki-67 index was >20%. Primary NEC of the appendix is extremely rare. To our knowledge, this is the first case report of an appendiceal NEC that meets the 2010 diagnostic criteria of the World Health Organization.
CONCLUSION:
Due to its non-specific clinical presentation, NEC is often misdiagnosed as appendicitis; however, it can advance rapidly and carries a very poor prognosis, despite chemotherapy. In the future, a treatment protocol for immunohistochemical analyses should be established to improve the survival rate.
AuthorsKodai Tomioka, Yoshihiro Fukoe, Yugen Lee, Masahiro Lee, Yusuke Wada, Takeshi Aoki, Masahiko Murakami
JournalAnticancer research (Anticancer Res) Vol. 33 Issue 6 Pg. 2635-8 (Jun 2013) ISSN: 1791-7530 [Electronic] Greece
PMID23749920 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • CD56 Antigen
  • Chromogranins
  • Ki-67 Antigen
  • SYP protein, human
  • Synaptophysin
Topics
  • Appendectomy
  • Appendiceal Neoplasms (diagnosis, diagnostic imaging, surgery)
  • Appendicitis (diagnosis)
  • Appendix (pathology, surgery)
  • CD56 Antigen (metabolism)
  • Carcinoma, Neuroendocrine (diagnosis, diagnostic imaging, surgery)
  • Chromogranins (metabolism)
  • Diagnosis, Differential
  • Female
  • Humans
  • Ki-67 Antigen (metabolism)
  • Laparoscopy
  • Middle Aged
  • Radiography
  • Synaptophysin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: